vs

Side-by-side financial comparison of BILL Holdings, Inc. (BILL) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

BILL Holdings, Inc. is the larger business by last-quarter revenue ($414.7M vs $217.5M, roughly 1.9× Tilray Brands, Inc.). BILL Holdings, Inc. runs the higher net margin — -0.6% vs -20.7%, a 20.0% gap on every dollar of revenue. On growth, BILL Holdings, Inc. posted the faster year-over-year revenue change (14.4% vs 3.1%). Over the past eight quarters, BILL Holdings, Inc.'s revenue compounded faster (13.3% CAGR vs 7.5%).

BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

BILL vs TLRY — Head-to-Head

Bigger by revenue
BILL
BILL
1.9× larger
BILL
$414.7M
$217.5M
TLRY
Growing faster (revenue YoY)
BILL
BILL
+11.3% gap
BILL
14.4%
3.1%
TLRY
Higher net margin
BILL
BILL
20.0% more per $
BILL
-0.6%
-20.7%
TLRY
Faster 2-yr revenue CAGR
BILL
BILL
Annualised
BILL
13.3%
7.5%
TLRY

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
BILL
BILL
TLRY
TLRY
Revenue
$414.7M
$217.5M
Net Profit
$-2.6M
$-44.9M
Gross Margin
79.8%
26.4%
Operating Margin
-4.4%
-10.2%
Net Margin
-0.6%
-20.7%
Revenue YoY
14.4%
3.1%
Net Profit YoY
-107.7%
47.4%
EPS (diluted)
$-0.03
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BILL
BILL
TLRY
TLRY
Q4 25
$414.7M
$217.5M
Q3 25
$395.7M
$209.5M
Q2 25
$383.3M
$224.5M
Q1 25
$358.2M
$185.8M
Q4 24
$362.6M
$210.9M
Q3 24
$358.4M
$200.0M
Q2 24
$343.7M
$229.9M
Q1 24
$323.0M
$188.3M
Net Profit
BILL
BILL
TLRY
TLRY
Q4 25
$-2.6M
$-44.9M
Q3 25
$-3.0M
$-322.0K
Q2 25
$-7.1M
$-1.3B
Q1 25
$-11.6M
$-789.4M
Q4 24
$33.5M
$-85.3M
Q3 24
$8.9M
$-39.2M
Q2 24
$7.6M
$-31.7M
Q1 24
$31.8M
$-92.7M
Gross Margin
BILL
BILL
TLRY
TLRY
Q4 25
79.8%
26.4%
Q3 25
80.5%
27.4%
Q2 25
80.8%
30.1%
Q1 25
81.2%
28.0%
Q4 24
81.6%
29.0%
Q3 24
82.0%
29.8%
Q2 24
81.0%
35.8%
Q1 24
83.0%
26.2%
Operating Margin
BILL
BILL
TLRY
TLRY
Q4 25
-4.4%
-10.2%
Q3 25
-5.2%
1.0%
Q2 25
-5.8%
-643.1%
Q1 25
-8.1%
-409.0%
Q4 24
-6.0%
-20.0%
Q3 24
-2.1%
-18.3%
Q2 24
-6.5%
-7.2%
Q1 24
-8.6%
-43.6%
Net Margin
BILL
BILL
TLRY
TLRY
Q4 25
-0.6%
-20.7%
Q3 25
-0.7%
-0.2%
Q2 25
-1.8%
-566.9%
Q1 25
-3.2%
-424.9%
Q4 24
9.3%
-40.5%
Q3 24
2.5%
-19.6%
Q2 24
2.2%
-13.8%
Q1 24
9.8%
-49.2%
EPS (diluted)
BILL
BILL
TLRY
TLRY
Q4 25
$-0.03
$-0.41
Q3 25
$-0.03
$0.00
Q2 25
$0.02
$7.26
Q1 25
$-0.11
$-8.69
Q4 24
$-0.06
$-0.99
Q3 24
$0.08
$-0.04
Q2 24
$0.37
$-0.04
Q1 24
$0.00
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BILL
BILL
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$1.1B
$291.6M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$3.8B
$1.6B
Total Assets
$10.1B
$2.1B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BILL
BILL
TLRY
TLRY
Q4 25
$1.1B
$291.6M
Q3 25
$1.1B
$264.8M
Q2 25
$1.0B
$256.4M
Q1 25
$1.0B
Q4 24
$1.6B
$252.2M
Q3 24
$853.5M
$280.1M
Q2 24
$985.9M
$260.5M
Q1 24
$952.5M
$225.9M
Total Debt
BILL
BILL
TLRY
TLRY
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$914.8M
Q2 24
$914.0M
Q1 24
$1.1B
Stockholders' Equity
BILL
BILL
TLRY
TLRY
Q4 25
$3.8B
$1.6B
Q3 25
$3.9B
$1.5B
Q2 25
$3.9B
$1.5B
Q1 25
$3.9B
$2.7B
Q4 24
$3.8B
$3.5B
Q3 24
$4.0B
$3.5B
Q2 24
$4.1B
$3.4B
Q1 24
$4.1B
$3.4B
Total Assets
BILL
BILL
TLRY
TLRY
Q4 25
$10.1B
$2.1B
Q3 25
$10.2B
$2.1B
Q2 25
$10.1B
$2.1B
Q1 25
$9.6B
Q4 24
$9.7B
$4.2B
Q3 24
$9.0B
$4.3B
Q2 24
$9.2B
$4.2B
Q1 24
$9.1B
$4.2B
Debt / Equity
BILL
BILL
TLRY
TLRY
Q4 25
0.48×
Q3 25
0.48×
Q2 25
0.44×
Q1 25
0.43×
Q4 24
0.44×
Q3 24
0.23×
Q2 24
0.22×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BILL
BILL
TLRY
TLRY
Operating Cash FlowLast quarter
$105.3M
$-8.5M
Free Cash FlowOCF − Capex
$103.8M
FCF MarginFCF / Revenue
25.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$378.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BILL
BILL
TLRY
TLRY
Q4 25
$105.3M
$-8.5M
Q3 25
$96.9M
$-1.3M
Q2 25
$83.8M
$-12.8M
Q1 25
$99.5M
$-5.8M
Q4 24
$78.7M
$-40.7M
Q3 24
$88.6M
$-35.3M
Q2 24
$78.6M
$30.7M
Q1 24
$66.8M
$-15.4M
Free Cash Flow
BILL
BILL
TLRY
TLRY
Q4 25
$103.8M
Q3 25
$95.6M
Q2 25
$81.0M
$-19.1M
Q1 25
$98.4M
$-20.2M
Q4 24
$78.3M
$-46.2M
Q3 24
$88.6M
$-42.0M
Q2 24
$78.4M
$21.0M
Q1 24
$66.8M
$-24.9M
FCF Margin
BILL
BILL
TLRY
TLRY
Q4 25
25.0%
Q3 25
24.1%
Q2 25
21.1%
-8.5%
Q1 25
27.5%
-10.9%
Q4 24
21.6%
-21.9%
Q3 24
24.7%
-21.0%
Q2 24
22.8%
9.1%
Q1 24
20.7%
-13.2%
Capex Intensity
BILL
BILL
TLRY
TLRY
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.7%
2.8%
Q1 25
0.3%
7.8%
Q4 24
0.1%
2.6%
Q3 24
0.0%
3.4%
Q2 24
0.1%
4.2%
Q1 24
0.0%
5.1%
Cash Conversion
BILL
BILL
TLRY
TLRY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.35×
Q3 24
9.94×
Q2 24
10.35×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BILL
BILL

Accounts Payable And Accounts Receivable Solutions$185.9M45%
Spend And Expense Interchange Revenue$166.5M40%
Interest On Funds Held For Customers$39.5M10%
Embedded And Other Solutions$22.8M5%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons